Literature DB >> 11232696

Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora.

S M Riordan1, C J McIver, D Wakefield, V M Duncombe, M C Thomas, T D Bolin.   

Abstract

OBJECTIVE: The aim of this study was to investigate the separate effects of indigenous oropharyngeal- and colonic-type flora on small intestinal mucosal immunity and morphometry in small intestinal bacterial overgrowth (SIBO).
METHODS: A duodenal aspirate and random biopsies of underlying mucosa were obtained from 52 adult subjects (age range, 18-90 yr; median, 60 yr) without disorders that may otherwise disturb small intestinal histology or mucosal immunity. Villus height, crypt depth, villus/crypt ratios, counts of intraepithelial lymphocytes (IELs) and lamina propria total mononuclear cells, IgA, IgM, and IgG plasma cells, mast cells, and B and T lymphocytes were determined in relation to the presence or absence of SIBO and the nature of the overgrowth flora in all subjects. CD4+ve and CD8+ve T-cell counts were determined in 24 subjects.
RESULTS: SIBO was present in 26 of 52 (50%) subjects. Overgrowth flora included colonic-type bacteria in 20 subjects and oropharyngeal-type flora alone in 6 subjects. Lamina propria IgA plasma cell counts were significantly increased in subjects with SIBO, irrespective of whether the overgrowth flora comprised oropharyngeal-type flora alone or included colonic-type bacteria. Neither villus height, crypt depth, villus/crypt ratios, nor total or other mononuclear cell counts in lamina propria differed significantly between subjects with and without SIBO, irrespective of the nature of the overgrowth flora. IEL counts were significantly higher than in culture-negative subjects only when the overgrowth flora included colonic-type bacteria. Even then, IEL counts were within a range currently considered normal. A significant, inverse correlation between advancing age and IEL counts became apparent after adjusting for the effect of SIBO of colonic-type flora.
CONCLUSIONS: SIBO of oropharyngeal- and colonic-type flora are associated with differing disturbances of local duodenal mucosa. Nonetheless, these would not be readily apparent during routine histological assessment. Old age independently influences duodenal IEL counts.

Entities:  

Mesh:

Year:  2001        PMID: 11232696     DOI: 10.1111/j.1572-0241.2001.03533.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  18 in total

Review 1.  Small intestinal bacterial overgrowth syndrome.

Authors:  Jan Bures; Jiri Cyrany; Darina Kohoutova; Miroslav Förstl; Stanislav Rejchrt; Jaroslav Kvetina; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

2.  Small intestinal bacterial overgrowth: a comprehensive review.

Authors:  Andrew C Dukowicz; Brian E Lacy; Gary M Levine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-02

3.  Small intestinal bacterial overgrowth in inflammatory bowel disease.

Authors:  Ayesha Shah; Gerald Holtmann
Journal:  Indian J Gastroenterol       Date:  2022-01-15

4.  Ear, nose and throat (ENT) manifestations and complications of reflux.

Authors:  Sabrina Brar; Carolina Watters; Natalie Watson; Martin Birchall; Yakubu Karagama
Journal:  Frontline Gastroenterol       Date:  2022-06-07

5.  Pediatric small intestine bacterial overgrowth in low-income countries.

Authors:  Jeffrey R Donowitz; William A Petri
Journal:  Trends Mol Med       Date:  2014-11-15       Impact factor: 11.951

6.  Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota.

Authors:  Susan V Lynch; Katherine C Goldfarb; Yvette K Wild; Weidong Kong; Robert C De Lisle; Eoin L Brodie
Journal:  Gut Microbes       Date:  2012-10-12

7.  Small Intestine Bacterial Overgrowth and Environmental Enteropathy in Bangladeshi Children.

Authors:  Jeffrey R Donowitz; Rashidul Haque; Beth D Kirkpatrick; Masud Alam; Miao Lu; Mamun Kabir; Shahria Hafiz Kakon; Bushra Zarin Islam; Sajia Afreen; Abu Musa; Shaila Sharmeen Khan; E Ross Colgate; Marya P Carmolli; Jennie Z Ma; William A Petri
Journal:  MBio       Date:  2016-01-12       Impact factor: 7.867

Review 8.  Implication of the intestinal microbiome in complications of cirrhosis.

Authors:  Mamatha Bhat; Bianca M Arendt; Venkat Bhat; Eberhard L Renner; Atul Humar; Johane P Allard
Journal:  World J Hepatol       Date:  2016-09-28

Review 9.  Treating the Metabolic Syndrome by Fecal Transplantation-Current Status.

Authors:  Stephen D H Malnick; David Fisher; Marina Somin; Manuela G Neuman
Journal:  Biology (Basel)       Date:  2021-05-20

10.  Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.

Authors:  Anne Hafer; Sigrid Krämer; Swantje Duncker; Martin Krüger; Michael P Manns; Stephan C Bischoff
Journal:  BMC Gastroenterol       Date:  2007-09-04       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.